Exploring Patient and Staff Experience of Using iPads for PPI Activity (LEAP)
Patients' and Healthcare Professionals' Experience of Using Apple iPads to Conduct Patient and Public Involvement Activity - a Qualitative Study
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
There is a long overdue push to get patients engaged at the earliest stage possible of the research cycle so there is earlier collaboration between the public/patients and the researcher rather than much later on in the research process. For this reason there are successful patient and public meetings that occur in various specialities within the NHS. However, attending these meetings can be difficult as timings for multiple people to attend at the same physical location can be logistically difficult. It can be further compounded if potential members are unable to attend due to their illness. For example, patients may be on home oxygen and therefore may not be selected by the facilitator or perhaps they themselves may decide to exclude themselves.
Previous research has had an online forum to engage the public/patients with the research process. However, the findings were that there was room to improve from an engagement perspective and furthermore, the real-time communication was limited due to how forums functions.
For this reason, the investigators have suggested using iPads so the investigators can have virtual meetings which negates the need to attend meetings physically. The investigators have used iPads instead of other tablets due to their higher encryption standards and because the in-built FaceTime is easier to use than other systems that install a separate application. Virtual meetings where a group of people are not in the same physical location and are communicating via telephone or the internet. Many patients who may not have been considered/been approached about being part of PPI can now participate virtually. In addition, the time commitment is significantly reduced as it would only involve the time the meeting would be held and not the travel time, which can be extensive.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Nottingham, United Kingdom, NG5 1PB
- Nottingham University Hospitals NHS Trust
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
- Participants in the PPI group and allocated an iPad: focus groups will be conducted either on hospital site or remotely using iPads.
- Participants in PPI and not allocated an iPad: focus groups will be conducted on NUH premises.
- Healthcare professionals involved in PPI activity with participants using iPad: docus group will be conducted at NUH
Description
Inclusion Criteria:
- Adults aged 18 and over
- Part of a respiratory medicine PPI group or a PPI group that will be started prior to consent into the study at Nottingham University Hospital Trust
Exclusion Criteria:
- Adults lacking mental capacity
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Patients With iPads
Patients who have been assigned an iPad to complete their PPI sessions remotely
|
|
Patients Without iPads
Patients who will continue to attend the classic face to face PPI meetings
|
|
Staff
Staff who will give their opinions on the use of iPads against normal PPI methods
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Use of technology to perform remote PPI
Time Frame: Up to 12months
|
To explore the patient and staff experience of using iPads for PPI sessions instead of physically attending meetings.
Focus groups were used and were analysed using the DeLone model of information systems as the theoretical framework.
|
Up to 12months
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 19RM008
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.